Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Adial Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −2 vs. Q1 2023
- Shares held
- 2.34M
- −168.4K (−6.7%) vs. Q1 2023
- Total value
- $488.2K
- −$388.7K (−44.3%) vs. Q1 2023
- New holders
- 2
- 2 more added
- Sold out
- 4
- 6 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $334.6K |
| Q1 2026 | 15 | $63.8K |
| Q4 2025 | 24 | $778.4K |
| Q3 2025 | 17 | $214.8K |
| Q2 2025 | 17 | $70.8K |
| Q1 2025 | 14 | $152.7K |
| Q4 2024 | 15 | $298.1K |
| Q3 2024 | 12 | $195.9K |
| Q2 2024 | 16 | $328.0K |
| Q1 2024 | 16 | $236.2K |
| Q4 2023 | 17 | $500.0K |
| Q3 2023 | 11 | $164.2K |
| Q2 2023 | 21 | $488.2K |
| Q1 2023 | 23 | $876.9K |
| Q4 2022 | 23 | $359.2K |
| Q3 2022 | 28 | $692.1K |
| Q2 2022 | 26 | $2.27M |
| Q1 2022 | 23 | $6.38M |
| Q4 2021 | 24 | $3.64M |
| Q3 2021 | 21 | $5.50M |
| Q2 2021 | 19 | $3.15M |
| Q1 2021 | 20 | $1.95M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Adial Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Manchester Capital Management LLC | 1,202,452 | $250.4K | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 203,358 | $42.3K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 194,364 | $40.5K | 0.00% | −31,491−13.9% | Reduced |
| Susquehanna International Group, LLP | 180,285 | $37.5K | 0.00% | −41,998−18.9% | Reduced |
| Geode Capital Management, LLC | 137,464 | $28.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 107,100 | $22.0K | 0.00% | +6,200+6.1% | Added |
| Raffa Wealth Management, LLC | 52,334 | $10.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 52,354 | $10.9K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 36,461 | $8.00K | 0.00% | 00.0% | Unchanged |
| Truist Financial Corp | 33,862 | $7.05K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 29,705 | $6.18K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 26,473 | $6.00K | 0.00% | −19,521−42.4% | Reduced |
| Advisor Group Holdings, Inc. | 24,046 | $5.00K | 0.00% | +700+3.0% | Added |
| Two Sigma Securities, LLC | 20,691 | $4.31K | 0.00% | −28,057−57.6% | Reduced |
| Two Sigma Investments, LP | 17,623 | $3.67K | 0.00% | −84−0.5% | Reduced |
| Envestnet Asset Management Inc | 13,088 | $2.73K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 10,000 | $2.08K | 0.00% | +10,000 | New |
| Morgan Stanley | 535 | $111 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 187 | $39 | 0.00% | −732−79.7% | Reduced |
| Benjamin F. Edwards & Company, Inc. | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 964 | $0 | 0.00% | +964 | New |
| Brown Advisory Inc | 0 | $0 | 0.00% | −26,040−100.0% | Sold out |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −10,630−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,748−100.0% | Sold out |